Microtesla Magnetic Therapy (MMT) is designed for broad, noninvasive brain exposure
MMT delivers low-intensity radiofrequency magnetic fields through a lightweight, wearable headset and a tabletop console. Treatment requires no electrodes, has virtually no sensation, and can be administered comfortably at home under clinical oversight.
Why MMT is different
Excellent safety profile in first human study
Zero serious adverse events in our first-in-human feasibility study (n=30) (2026). No systemic exposure, no off-target effects observed, no discomfort.1
Broad multipathway activity
MMT showed anti-inflammatory and neuroprotective activity across many cell types including neurons and glia, which could result in bigger effects across multiple disease states.2
Designed for home treatment
All 30 participants who completed the study received seven of eight treatments at home. Participants rated the MMT 4.8 out of 5 for ease of use and convenience.
Evidence of Cellular Repair
Strong signals that MMT restores cellular function and promotes durable repair, not temporary symptom management.2
Demonstrated in a triple-blind, randomized, sham-controlled feasibility study
MMT drives a coordinated, systems shift from inflammation toward repair as measured across cognition, mood, and 11,000 plasma proteins measured in peripheral blood.
Findings of feasibility study to be confirmed in larger controlled trials.
Full results, effect sizes, and statistical detail are in the preprint.
The clinical response to MMT is accompanied by focused plasma proteomic remodeling, with responder-linked signals converging on inflammation resolution and repair-associated biology.4
“This is the first data I have seen suggesting that
restoration of lost function may be possible.”
